Business Context and Reporting Period
This Form 8-K Current Report was filed by Phibro Animal Health Corporation on November 5, 2024. The filing reports a corporate event regarding the declaration of a quarterly cash dividend.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed is related to the dividend declaration:
- Dividend Amount: $0.12 per share
- Applicable Shares: Class A Common Stock and Class B Common Stock
- Record Date: November 27, 2024
- Payment Date: December 18, 2024
Material Changes
The filing does not report material changes to financial performance, operations, or capital structure compared to prior periods. The sole material event is the Board of Directors' declaration of the quarterly dividend.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly serves to announce the dividend details as outlined in the press release filed as Exhibit 99.1.
Investor Verification Checklist
- Verify the Record Date (November 27, 2024) to confirm eligibility for the dividend.
- Confirm the Payment Date (December 18, 2024) for cash flow planning.
- Review the attached Exhibit 99.1 (Press Release) for any additional context regarding the dividend policy.
- Note that this filing does not provide updated financial performance data; refer to the most recent 10-Q or 10-K for operational metrics.